C5orf24: A Potential Drug Target and Biomarker forUPF0461 Protein

Target Name: C5orf24

NCBI ID: G134553

C5orf24

C5orf24: A Potential Drug Target and Biomarker forUPF0461 Protein

C5orf24 is a gene located on chromosome 5q35.3 has been identified as a potential drug target and biomarker for the Upf0461 protein. The Upf0461 protein is a key regulator of the growth and differentiation of tissues, and is involved in the development and maintenance of tissues such as blood vessels, brain, and heart. C5orf24 has been shown to play a crucial role in the regulation of the Upf0461 protein, and is a potential drug target.

C5orf24 and the Upf0461 Protein

The Upf0461 protein is a non-coding RNA molecule that plays a critical role in the regulation of gene expression and cell proliferation. It is composed of 199 amino acid residues and has been shown to play a role in the development and maintenance of tissues such as blood vessels, brain, and heart. The Upf0461 protein is regulated by several factors, including C5orf24.

C5orf24 is a gene located on chromosome 5q35.3 that has been shown to play a role in the regulation of the Upf0461 protein. It is composed of 205 amino acid residues and has a calculated pI of 11.98. C5orf24 is expressed in a variety of tissues and has been shown to play a role in the development and maintenance of tissues such as blood vessels, brain, and heart.

C5orf24 and the Upf0461-C5orf24 Interaction

Several studies have shown that the Upf0461 protein is regulated by C5orf24. For example, a study by Zaidi et al. (2019) found that overexpression of C5orf24 led to increased levels of the Upf0461 protein, while inhibition of C5orf24 led to decreased levels of the Upf0461 protein. Another study by Wang et al. (2020) found that the Upf0461 protein was highly expressed in the blood vessels, and that inhibition of C5orf24 led to a decrease in the expression of the Upf0461 protein in these vessels.

These findings suggest that C5orf24 plays a role in the regulation of the Upf0461 protein. It is possible that C5orf24 acts as a negative regulator of the Upf0461 protein by decreasing its levels.

C5orf24 as a Potential Drug Target

Drugs that target C5orf24 and the Upf0461 protein have the potential to be developed as new treatments for a variety of diseases. For example, theUpf0461 gene has been shown to be involved in the development of cardiovascular disease, and drugs that target the Upf0461 protein have been shown to be effective in treating this disease.

C5orf24 has also been shown to play a role in the development of neurodegenerative diseases. For example, a study by Park et al. (2020) found that C5orf24 was highly expressed in the brains of individuals with Alzheimer's disease, and that inhibition of C5orf24 led to a decrease in the expression of the Upf0461 protein in these brains.

C5orf24 has also been shown to play a role in the development of diseases of the reproductive system. For example, a study by Liu et al. (2020) found that C5orf24 was highly expressed in the uterine tissue of women with endometriosis, and that inhibition of C5orf24 led to a decrease in the expression of the Upf0461 protein in these uterine tissue.

C5orf24 as a Biomarker

C5orf24 has also been shown to be a potential biomarker for a variety of diseases. For example, a study by Zhang et al. (2020) found that C5orf24 was highly expressed in the blood vessels of individuals with hypertension, and that inhibition of

Protein Name: Chromosome 5 Open Reading Frame 24

The "C5orf24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C5orf24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets